OTCMKTS:THERF - Theratechnologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.32 -0.05 (-0.93 %) (As of 03/24/2019 12:15 PM ET)Previous Close$5.32Today's Range$5.22 - $5.3552-Week Range$5.0905 - $11.25Volume79,588 shsAverage Volume60,227 shsMarket Capitalization$409.11 millionP/E RatioN/ADividend YieldN/ABeta0.56 ProfileDiscussionAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada. Receive THERF News and Ratings via Email Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:THERF Previous SymbolNASDAQ:THER CUSIPN/A CIKN/A Webwww.theratech.com Phone514-336-7800Debt Debt-to-Equity Ratio1.38 Current Ratio2.89 Quick Ratio2.52Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$45.18 million Price / Sales9.06 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book12.09Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,640,000.00 Net Margins-10.42% Return on Equity-7.73% Return on Assets-3.45%Miscellaneous EmployeesN/A Outstanding Shares76,900,000Market Cap$409.11 million Next Earnings Date4/4/2019 (Estimated) OptionableNot Optionable Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions What is Theratechnologies' stock symbol? Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF." How were Theratechnologies' earnings last quarter? Theratechnologies Inc (OTCMKTS:THERF) issued its quarterly earnings data on Thursday, February, 21st. The company reported ($0.02) earnings per share for the quarter. The firm earned $13.85 million during the quarter. Theratechnologies had a negative return on equity of 7.73% and a negative net margin of 10.42%. View Theratechnologies' Earnings History. When is Theratechnologies' next earnings date? Theratechnologies is scheduled to release their next quarterly earnings announcement on Thursday, April 4th 2019. View Earnings Estimates for Theratechnologies. What is the consensus analysts' recommendation for Theratechnologies? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Theratechnologies. Has Theratechnologies been receiving favorable news coverage? News stories about THERF stock have been trending positive on Sunday, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Theratechnologies earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. Who are some of Theratechnologies' key competitors? Some companies that are related to Theratechnologies include Pacira Pharmaceuticals (PCRX), Allakos (ALLK), Opko Health (OPK), Puma Biotechnology (PBYI), Prestige Consumer Healthcare (PBH), Wave Life Sciences (WVE), Innoviva (INVA), Gossamer Bio (GOSS), Aimmune Therapeutics (AIMT), Clovis Oncology (CLVS), Cambrex (CBM), Phibro Animal Health (PAHC), Corcept Therapeutics (CORT), Theravance Biopharma (TBPH) and TherapeuticsMD (TXMD). What other stocks do shareholders of Theratechnologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Theratechnologies (TH), Allena Pharmaceuticals (ALNA), Micron Technology (MU), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), Obseva (OBSV), GTX (GTXI), Sorrento Therapeutics (SRNE), Aurora Cannabis (ACBFF) and Shopify (SHOP). Who are Theratechnologies' key executives? Theratechnologies' management team includes the folowing people: Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53) How do I buy shares of Theratechnologies? Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Theratechnologies' stock price today? One share of THERF stock can currently be purchased for approximately $5.32. How big of a company is Theratechnologies? Theratechnologies has a market capitalization of $409.11 million and generates $45.18 million in revenue each year. What is Theratechnologies' official website? The official website for Theratechnologies is http://www.theratech.com. How can I contact Theratechnologies? Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected] MarketBeat Community Rating for Theratechnologies (OTCMKTS THERF)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 66 (Vote Outperform)Underperform Votes: 65 (Vote Underperform)Total Votes: 131MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe THERF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THERF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/24/2019 by MarketBeat.com StaffFeatured Article: Why are analyst ratings important in trading stocks?